Meet our Advisory Board

NeuroPsyAI has an experienced group of scientific, management and business advisors.

Prof. Sir Robin Murray

Consultant Psychiatrist and Professor

Professor of Psychiatric Research at the Institute of Psychiatry, Psychology and Neuroscience of King’s College London, where he has been Dean.

Robin has over 50 years of expertise in schizophrenia, over 100.000 citations and an H-index of 159. He has been the president of the European Association of Psychiatrists; now the European Psychiatric Association; a Fellow of the Royal Society and of the Royal College of Psychiatrists; and Chairman of the Schizophrenia Commission which reviewed in detail the care of people with psychosis in England. He was Robin was knighted in the 2011 New Year Honours for his services to medicine.

Prof. Dag Aarsland

Consultant Psychiatrist and Professor

Chair of Old Age Psychiatry at the Institute of Psychiatry, Psychology and Neuroscience of King’s College London

Also a Director of Research at the University of Stavanger’s Centre for Age-Related Medicine, Dag has been a Professor of Clinical Dementia research at Karolinska Institutet, and Director of the Norwegian Neuropsychiatric Association. Renowned in Lewy Body Dementia and Parkinson’s Disease, he has >45000 citations an H-index of 103.

Prof. Ray Chaudhuri

Consultant Neurologist and Professor

Medical director of the National Parkinson Foundation International Centre of Excellence of King’s College London

A Professor in Neurology/Movement Disorders, Ray is on the editorial board of Parkinsonism and Related Disorders and Journal of Parkinson’s Disease, among other medical journals. He has reached 18.000 citations and an H-index of 65.

Prof. Nikolaos Koutsouleris

Consultant Psychiatrist and Professor

Professor at Department of Psychiatry and Psychotherapy of the University of Munich.

Nikolaos is the coordinator of PRONIA, an EU initiative to improve the early detection of psychotic diseases, and a developer of Artificial Intelligence methods applied to neuroimaging data to improve healthcare in neuropsychiatric illnesses.

Prof. Pedro Almeida

Biomedical Engineer and Professor

Director of the Institute of Biophysics and Biomedical Engineering, and Professor in Biomedical Engineering and Physics at the Faculty of Sciences, of the University of Lisbon. Expert in Nuclear Medicine.

Eng. Francisca Leite

Physicist and Innovation Director

Director of Training, Development and Innovation at Luz Saúde, the largest private health group in Portugal.

Francisca has a PhD in Neuroimaging from Harvard – MIT Division of Health Sciences and Technology, and was Associate and Engagement Manager in McKinsey & Company for 6 years.

Prof. Angus Kingon

Professor and Entrepeneur

Professor of Engineering and Professor of Entrepreneurship and Organizational Studies at Brown University. Angus is the academic director of the IE Brown Executive MBA.

He has over 15.000 citations, and H-index of 61 and 15 patents granted (in 13 countries), being awarded several research awards. He was the co-winner of the Price Foundation Award as Innovative Entrepreneurship Educator in 2006.

Mr. Ralph Arnold

Investor and Entrepeneur

Healthcare Mergers & Acquisitions Advisor and Digital Health Investor. Ralph was the Aventis (now Sanofi) Head of M&A, co-founded Symplybussiness.co.uk and TransAct, and built the ventures unit for Bayer.

Ralph is an active investor in digital health startups, for more than 20 years experience.

Mr. José Villa de Freitas

Insurance Marketing Director

Marketing Director at Insurance company, Fidelidade, the largest in Portugal.

José has been a marketing manager in PEUGEOT Portugal, and Caixa Geral de Depósitos, with more than 20 years experience.